267 related articles for article (PubMed ID: 34139010)
1. Circulating Advanced Glycation End Products and Their Soluble Receptors in Relation to All-Cause and Cardiovascular Mortality: A Systematic Review and Meta-analysis of Prospective Observational Studies.
Sharifi-Zahabi E; Sharafabad FH; Abdollahzad H; Malekahmadi M; Rad NB
Adv Nutr; 2021 Dec; 12(6):2157-2171. PubMed ID: 34139010
[TBL] [Abstract][Full Text] [Related]
2. Associations of circulating advanced glycation end products and their soluble receptors with cancer risk: A systematic review and meta-analysis of observational studies.
Hajizadeh-Sharafabad F; Shojaei-Zarghani S; Sharifi-Zahabi E; Gerami F; Pashaei MR
Glycoconj J; 2024 Feb; 41(1):35-46. PubMed ID: 38498243
[TBL] [Abstract][Full Text] [Related]
3. Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients.
Assiri AMA; Kamel HFM; ALrefai AA
Med Sci (Basel); 2018 May; 6(2):. PubMed ID: 29789493
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study.
Sabbatinelli J; Castiglione S; Macrì F; Giuliani A; Ramini D; Vinci MC; Tortato E; Bonfigli AR; Olivieri F; Raucci A
Cardiovasc Diabetol; 2022 Jun; 21(1):95. PubMed ID: 35668468
[TBL] [Abstract][Full Text] [Related]
5. The role of sRAGE in cardiovascular diseases.
Delrue C; Delanghe JR; Speeckaert MM
Adv Clin Chem; 2023; 117():53-102. PubMed ID: 37973322
[TBL] [Abstract][Full Text] [Related]
6. Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.
Nin JW; Jorsal A; Ferreira I; Schalkwijk CG; Prins MH; Parving HH; Tarnow L; Rossing P; Stehouwer CD
Diabetes; 2010 Aug; 59(8):2027-32. PubMed ID: 20522598
[TBL] [Abstract][Full Text] [Related]
7. Association of four differently processed diets with plasma and urine advanced glycation end products and serum soluble receptor for advanced glycation end products concentration in healthy dogs.
Bridglalsingh S; Archer-Hartmann S; Azadi P; Barbier de La Serre C; Remillard RL; Sunvold GD; Bartges JW
J Anim Physiol Anim Nutr (Berl); 2024 May; 108(3):735-751. PubMed ID: 38279966
[TBL] [Abstract][Full Text] [Related]
8. Association of plasma advanced glycation end-products and their soluble receptor with type 2 diabetes among Chinese adults.
Chen L; Wang Q; Lv Y; Xu W; Jiang G; Li Y; Luo P; He R; Liu L
Diabetes Metab Res Rev; 2024 Feb; 40(2):e3735. PubMed ID: 37817474
[TBL] [Abstract][Full Text] [Related]
9. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
[TBL] [Abstract][Full Text] [Related]
10. Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients.
Nakashima A; Carrero JJ; Qureshi AR; Miyamoto T; Anderstam B; Bárány P; Heimbürger O; Stenvinkel P; Lindholm B
Clin J Am Soc Nephrol; 2010 Dec; 5(12):2213-9. PubMed ID: 20847094
[TBL] [Abstract][Full Text] [Related]
11. Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals.
Scavello F; Tedesco CC; Castiglione S; Maciag A; Sangalli E; Veglia F; Spinetti G; Puca AA; Raucci A
Biomark Med; 2021 Aug; 15(11):785-796. PubMed ID: 34236256
[TBL] [Abstract][Full Text] [Related]
12. Soluble receptor for advanced glycation end products (sRAGE) is associated with obesity rates: a systematic review and meta-analysis of cross-sectional study.
Tayyib NA; Ramaiah P; Alshahrani SH; Margiana R; Almalki SG; Kareem AK; Zabibah RS; Shbeer AM; Ali SHJ; Mustafa YF
BMC Endocr Disord; 2023 Dec; 23(1):275. PubMed ID: 38102636
[TBL] [Abstract][Full Text] [Related]
13. The role of advanced glycation end products in vascular aging: which parameter is the most suitable as a biomarker?
Mayer O; Gelžinský J; Seidlerová J; Mateřánková M; Mareš Š; Svobodová V; Trefil L; Cífková R; Filipovský J
J Hum Hypertens; 2021 Mar; 35(3):240-249. PubMed ID: 32203073
[TBL] [Abstract][Full Text] [Related]
14. Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.
Pertynska-Marczewska M; Merhi Z
Reprod Sci; 2015 Jul; 22(7):774-82. PubMed ID: 25228634
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
Prasad K; Tiwari S
Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
[TBL] [Abstract][Full Text] [Related]
16. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
[TBL] [Abstract][Full Text] [Related]
17. Association between advanced glycation end products, their soluble receptor, and mortality in the general population: Results from the CARLA study.
Ebert H; Lacruz ME; Kluttig A; Simm A; Greiser KH; Tiller D; Kartschmit N; Mikolajczyk R
Exp Gerontol; 2020 Mar; 131():110815. PubMed ID: 31857132
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitus.
Farhan SS; Hussain SA
Diabetes Metab Syndr; 2019; 13(4):2457-2461. PubMed ID: 31405660
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.
Semba RD; Ferrucci L; Sun K; Beck J; Dalal M; Varadhan R; Walston J; Guralnik JM; Fried LP
Aging Clin Exp Res; 2009 Apr; 21(2):182-90. PubMed ID: 19448391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]